NMDAR2C/GRIN2C (extracellular) Blocking Peptide (#BLP-GC018) is the original antigen used for immunization during Anti-NMDAR2C (GRIN2C) (extracellular) Antibody (#AGC-018) generation. The blocking peptide binds and ‘blocks’ Anti-NMDAR2C/GRIN2C (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of rat brain membrane:
- Western blot analysis of mouse brain lysate:
- Expression of NMDAR2C in rat pancreasImmunohistochemical staining rat pancreas paraffin-embedded sections using Anti-NMDAR2C (GRIN2C) (extracellular) Antibody (#AGC-018), (1:100) followed by goat-anti-rabbit-AlexaFluor-594 (red) secondary antibody. Staining is present in endocrine cells of the Isles of Langerhans. Hoechst 33342 is used as the counterstain (blue).
- (C)RHRLWEMVGRWDH, corresponding to amino acid residues 365-377 of rat NMDAR2C (Accession Q00961).